Total hip arthroplasty (THA) and total knee arthroplasty (TKA) are common and successful orthopedic procedures, and as their frequency continues to increase substantially, the focus on limiting perioperative complications heightens. Intraoperative normothermia is recommended to minimize additional complications, but limited evidence exists regarding the effect of hypothermia on orthopedic patients. The purpose of this retrospective study was to determine the incidence of perioperative hypothermia in the setting of TKA and THA, and to evaluate its impact on complications and outcomes. The clinical records of 2580 consecutive patients who underwent TKA or THA at a single institution between January 1, 2011, and December 31, 2013 were reviewed. After excluding patients with complex or revision procedures, a total of 2397 patients comprised the study population. Patient demographic data, surgery-specific data, postoperative complications, length of hospital stay, and 30-day readmission were recorded. Patients with a mean intraoperative temperature less than 36°C were identified as hypothermic. Statistical analysis evaluated associations with hypothermia and the effect on complications and outcomes. The incidence of mean intraoperative hypothermia was 37%, 43.9%, and 32.6% for arthroplasty, THA, and TKA, respectively. General anesthesia was significantly associated with hypothermia (P<.001). Women and THA patients were at higher risk for hypothermia. In the arthroplasty and THA cohorts, longer operating room time and re-warmer use were associated with hypothermia (P=.010). Overall, hypothermia was associated with increased estimated blood loss, but no increase in associated transfusion was demonstrated (P=.006). Hypothermia was not associated with postoperative complications. [Orthopedics. 2017; 40(1): 56-63.] abstract cant financial burden associated with what have been deemed potentially avoidable perioperative complications have driven these measures. 5, 7, 11 All of these guidelines recommend maintenance of normothermia (defined as body temperature below 36°C) in the immediate perioperative period. [8] [9] [10] Although most recommendations in these guidelines are supported by an abundance of evidence, the rationale for the recommendation of normothermia is based on evidence outside the field of orthopedics and has been generally applied to all surgical patients. 12 Several reports have suggested that perioperative hypothermia occurs commonly and can be decreased by using active re-warming techniques. [13] [14] [15] [16] [17] [18] [19] [20] Other studies have indicated that perioperative hypothermia may increase intraoperative blood loss and the need for transfusion, impair wound healing, increase the risk of surgical site infection, and increase cardiovascular morbidity. [21] [22] [23] [24] [25] [26] [27] [28] [29] Interestingly, there is limited evidence regarding the role that perioperative normothermia plays in outcomes associated with orthopedic surgical procedures, and specifically TKA and THA. 30, 31 The purpose of this study was to determine the incidence of perioperative hypothermia in the setting of TKA and THA, and to evaluate the impact of hypothermia on complications and outcomes in the immediate postoperative period.
Materials and Methods
After receiving institutional review board approval, the clinical records of 2580 consecutive patients who underwent knee or hip arthroplasty at the authors' institution between January 1, 2011, and December 31, 2013 were reviewed. Data were collected from 6 fellowship-trained surgeons at 2 academically affiliated hospitals; the first hospital was a large urban tertiary care center, and the second was a suburban community hospital in a large metropolitan area. Three independent reviewers collected all data and performed extensive chart reviews. After excluding patients who underwent bilateral procedures or complex procedures, unicompartmental knee arthroplasty, and revision surgery, as well as patients with less than 6 weeks of follow-up data, a total of 2397 patients were included in the analysis. Of these 2397 patients, 1456 patients (60.7%) underwent TKA and 941 patients (39.3%) underwent THA.
Patient demographic data including age, gender, race, procedure, and side were recorded. Basic clinical data including body mass index, pre-and postoperative hemoglobin levels, and American Society of Anesthesiologists classification was recorded. Surgery-specific data recorded included type of anesthesia, length of surgery, use of an intraoperative active re-warming device, perioperative temperature measurements, estimated intraoperative blood loss (EBL), requirement for postoperative transfusion, intraoperative intravenous fluid administration, length of hospital stay, and 30-day readmission. Temperature measurements were obtained from the anesthesia record. Prior to November 2012, anesthesia records were recorded by hand and uploaded to patients' electronic medical record. After November 2012, patients' electronic medical records included electronic anesthesia records. To determine intraoperative temperature, all patients' intraoperative temperature measurements were averaged. Hypothermic patients were defined as those who showed a mean intraoperative temperature less than 36°C.
Postoperative complications were recorded and included superficial surgical site infection (SSSI), deep surgical site infection (DSSI), nonsurgical site infection (NSSI), symptomatic deep venous thrombosis, pulmonary embolism, myocardial infarction, and stroke. Superficial surgical site infection was defined as infection superficial to the fascia. Patients were identified as having DSSI if the infection was deep to the fascia and if they required reoperation including deep irrigation and debridement or removal of components for infection. Nonsurgical site infection was defined as systemic infection anatomically distant to the surgical site that required antibiotic treatment. Patients wore intermittent pneumatic compression devices during their hospital stay and received chemical VTE prophylaxis postoperatively. All patients received a dose of prophylactic antibiotics 60 minutes prior to surgical incision, and dosing was continued for 24 hours postoperatively.
Both institutions used warmed-air convection active re-warmers (Bair Hugger; 3M, St Paul, Minnesota) for intraoperative temperature management. The use of active re-warming during operative cases was determined by the anesthesiologist based on the following criteria: for patients under general anesthesia, an active re-warming device was used, and for patients under regional anesthesia only, active re-warming was used if intraoperative hypothermia was documented or if the operative duration was expected to be longer than 60 minutes. Pre-and postoperative temperature measurements were taken via skin probe thermometers (LCD Sensostrip; DeRoyal, Powell, Tennessee) by the nursing staff. Temperature measurements intraoperatively were taken at the discretion of the anesthesiologist or the certified registered nurse anesthetist, and were measured by skin probe, axillary temperature reading, or an esophageal temperature sensor (Covidien, Boulder, Colorado).
Statistical Analysis
Statistical analysis was performed on 3 cohorts: all arthroplasty, TKA only, and THA only. Patients were categorized as normothermic or hypothermic (mean intra- operative temperature <36°C). Categorical data are described using counts and column percentages, and compared using chisquare tests; continuous data are described using means and standard deviations, and compared using 2-group t tests. Adjusted odds ratios and 95% confidence intervals were obtained using multivariable logistic regression. The level of statistical significance was set at P<.05. All analyses were performed using SAS version 9.4 (SAS Institute Inc, Cary, North Carolina).
results
The overall incidence of intraoperative hypothermia was 37% for the combined arthroplasty cohort. The incidence of intraoperative hypothermia for the THA and TKA cohorts was 43.9% and 32.6%, respectively ( Figure) . The incidence of hypothermia was higher for patients undergoing THA, and women undergoing THA were significantly more likely to experience hypothermia ( Table 1) . No statistical differences were observed for any other demographic factor. Analysis of perioperative data revealed a significant association between general anesthesia and hypothermia in all cohort analyses (P<.001; Table  2 ). The arthroplasty cohort demonstrated increased EBL, but no correlation with increased transfusion was demonstrated (P=.006; Table 2 ). In the arthroplasty and THA cohorts, re-warmer use was associated with hypothermia (P<.002 and P<.001, respectively; Table 2 ). The THA group demonstrated an association between increased operating room time and hypothermia (P=.010; Table 2 ). Analysis of postoperative complications revealed no associations with hypothermia, and there was no increase in length of hospital stay or readmission ( Table 3) . Multivariate logistic regression was performed to identify risk factors influencing intraoperative hypothermia. This analysis noted a correlation between active re-warmer use and hypothermia in the ar- throplasty and THA cohorts, with longer operating room time also increasing the odds of hypothermia ( Table 4) .
discussion
Current guidelines (AHRQ, WHO, and SCIP) recommend perioperative normothermia as a goal of perioperative patient care, designed to decrease avoidable complications associated with surgery. [8] [9] [10] Most studies evaluating the success of these guidelines at decreasing SSI looked at bundled measure adherence effect, and little is known about the individual influence of each guideline measure. 30 There is a paucity of evidence regarding the effect of intraoperative hypothermia in the orthopedic literature, and the current study is the largest series that has evaluated the effect of intraoperative hypothermia on complications and outcomes in elective total joint arthroplasty.
The findings of the current study showed a strong association between general anesthesia and intraoperative hypothermia. This association was statistically significant and consistent for the combined arthroplasty cohort and both THA and TKA subgroup analyses. Thermoregulatory control is a complex system regulated by both the central and autonomic nervous systems. The use of general anesthesia has been implicated in intraoperative hypothermia. 32 Sessler 32 described the effects of general anesthesia as impairing central thermoregulatory control systems, such as vasoconstriction and shivering thresholds. In addition, thermoregulatory defenses are relatively impaired in elderly patients, who are the most likely to undergo total joint arthroplasty. Thus, general anesthesia use in elderly patients represents a unique compounded risk for intraoperative hypothermia, consistent with the findings of the current study. Neuraxial anesthesia demonstrates a lesser impairment of central thermoregulatory control but affects autonomic thermoregulation more profoundly and is compounded by patients' impaired behavioral thermal regulation in the perioperative period. 32 Thus, although patients undergoing regional anesthesia appear to exhibit hypothermia less commonly, they are not immune to intraoperative hypothermia and still require close temperature monitoring. Anesthetic choice appears to be a modifiable risk factor for intraoperative hypothermia in patients undergoing arthroplasty that potentially can be avoided, as regional anesthesia is effective and adequate for most orthopedic surgical interventions including THA and TKA. 33 The finding of female gender and THA as demonstrating higher probability of hypothermia correlates with evidence in the literature. 32 Perioperative hypothermia has been implicated with an increase in SSSI and NSSI, VTE events, cardiovascular morbidity, and length of hospital stay postoperatively. [21] [22] [23] [24] [25] [26] [27] [28] [29] 34, 35 The current study did not reveal any significant risk of these complications associated with intraoperative hypothermia. Specifically, intraoperative hypothermia was not associated with an increased rate of infection (NSSI, SSSI, or DSSI), VTE events (deep venous thrombosis or pulmonary embolism), myocardial infarction, or stroke. Rohrer and Natale 29 and Schmied et al 28 independently evaluated the effects of hypothermia on the coagulation cascade and on blood loss and requirement for postoperative transfusion. They found that hypothermia inhibited the coagulation cascade, increased blood loss, and increased the rate of blood transfusions in patients undergoing THA. The findings of the current study partially support this claim, as the arthroplasty and THA cohorts 39 recently found that up to 28% of patients undergoing TKA and THA experienced perioperative hypothermia despite active re-warming. The incidence in the current study was higher than in these reports; the overall rate of hypothermia was 37%, and the THA cohort was at higher risk than the TKA cohort (43.9% and 32.6%, respectively). Intraoperative hypothermia was more common in patients who received active re-warming in the arthroplasty and THA cohorts, both in univariate and multivariate modeling. The reason for this finding is likely multifactorial. At the current authors' institution, anesthesia was chosen based on an algorithm in which an active re-warming device was used in all patients undergoing surgery with general anesthesia, whereas an active re-warming device was used in patients undergoing surgery with regional anesthesia only if intraoperative hypothermia was documented or if the operating room time was expected to be longer than 60 minutes. The correlation observed most likely was the result of active re-warming devices being applied in response to intraoperative hypothermia, rather than as a preventative measure.
A limitation of the current study was the method used for measuring perioperative temperature. There was no standard protocol for measuring intraoperative temperature, and different methods were used based on multiple patient and anesthesia factors. Pre-and postoperatively, temperature was measured using skin surface probes. Intraoperatively, many factors contribute to temperature measurements. It is well documented that core body temperature measurements are accurate and reproducible (by urinary catheter, esophageal, or endotracheal probe, or with tympanic membrane measurement). 32 For patients who have neuraxial anesthesia, there are multiple issues with measuring accurate intraoperative temperature. Most patients receiving spinal anesthesia are not intubated, and esophageal and endotracheal probe measurement are not feasible.
In addition, neuraxial anesthesia requires patients to be exposed for a period of time while the anesthesia team administers the anesthetic. During this time, invasive core temperature measurement is not feasible, and temperature monitoring is performed with less accurate methods. Using urinary catheters with temperature probes is associated with increased cost considerations. The effect of this cost difference is unknown at the current authors' institution and certainly would differ from institution to institution.
For those patients undergoing general anesthesia, invasive core temperature monitoring can only be performed while the patient is anesthetized and cannot capture significant portions of time before intubation, leading up to extubation, and directly after extubation. In addition, the margin of error of the temperature devices used could not be determined because of the retrospective design of the study. However, the results of the current study are generalizable as many hospitals experience the same issues. Because limited evidence is available in the orthopedic literature, there is no distinct method for temperature monitoring in these patients. Perhaps a hybrid method of temperature monitoring is required, and further prospective study in this regard is required.
Other limitations to this study include the retrospective design, the 6-week follow-up length that potentially excludes late complications, and possible underpowering. The staff surgeon estimated intraoperative blood loss, and indications for transfusion were not standardized during the study time period. Thus, drawing conclusions regarding blood loss and transfusion rates is limited. The ambient temperature in the operating rooms was not standardized, which also could represent a potential confounder. Multiple studies have evaluated intraoperative hypothermia, but each has measured patient temperature by different, unstandardized methods. 12, 15, 21, 23, 39, 40 As with the current study, evaluation of intraoperative hypothermia has no standardized protocol, and results and any conclusions must be considered in light of this nonstandardized factor. To accurately study intraoperative hypothermia in orthopedic patients, standardized accurate temperature monitoring protocols in prospective trials are needed.
conclusion
The overall incidence of hypothermia was 37% (43.9% for THA and 32.6% for TKA), and general anesthesia was a significant risk factor for intraoperative hypothermia in patients undergoing total joint arthroplasty. Women undergoing THA were at increased risk of hypothermia, with prolonged operating room time increasing this risk. Hypothermia was associated with increased EBL but not postoperative transfusion rates. No association was found between hypothermia and infection, VTE, myocardial infarction, stroke, postoperative length of hospital stay, or 30-day readmission. Despite the use of an active re-warming device in more than 90% of cases, the incidence of hypothermia remained high.
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